EpiStack
Search
Search
Dark mode
Light mode
Explorer
Home
❯
EpiStack v1 — FLF competition
❯
analysis tests
❯
eggs1
❯
hypotheses
Folder: v1/analysis-tests/eggs1/hypotheses
13 items under this folder.
Jul 20, 2026
H-1 - Habitual whole-egg intake raises atherogenic LDL-ApoB and thereby CVD risk
Jul 20, 2026
H-10 - Egg intake has no material effect on blood lipids, CVD, or mortality across diverse global populations
Jul 20, 2026
H-11 - Egg's effect on atherogenic blood lipids is characterized in some way not listed above
Jul 20, 2026
H-12 - Egg's net effect on hard cardiovascular and mortality endpoints is not a single population-wide direction
Jul 20, 2026
H-13 - Egg's effect is essentially homogeneous across people with no stable protected subgroup or responder class
Jul 20, 2026
H-2 - Moderate egg intake around one per day is protective against CVD
Jul 20, 2026
H-3 - High egg intake increases all-cause mortality, especially in diabetics
Jul 20, 2026
H-4 - Egg intake is essentially neutral for ischemic heart disease
Jul 20, 2026
H-5 - Poor bioavailability of egg cholesterol explains its weak effect on plasma cholesterol
Jul 20, 2026
H-6 - Two eggs-day does not worsen cardiovascular risk factors in people with type 2 diabetes or prediabetes
Jul 20, 2026
H-7 - A stable, lifestyle-independent subset of hypo-responders exists for whom dietary cholesterol raises serum cholesterol little
Jul 20, 2026
H-8 - Dietary cholesterol's effect on serum cholesterol is real but saturating, small at high habitual intakes
Jul 20, 2026
H-9 - Moderate habitual egg intake is not associated with increased CVD risk in generally healthy Western adults
Graph View